Lexicon Pharmaceuticals (LXRX) Stock: Buy, Sell, or Hold?
LXRX - Lexicon Pharmaceuticals, Inc.
$1.82
0.00 (0.00%)
▲
5d:
+1.39%
30d:
-18.75%
90d:
-21.55%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LXRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LXRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LXRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LXRX is currently trading at $1.82, which is considered oversold relative to its 30-day fair value range of $1.91 to $2.26.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.19.
Market Sentiment: LXRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.55 (+149.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.76, while resistance sits at $2.19.
Market Sentiment: LXRX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.55 (+149.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.91 -
$2.26
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 149.8% below Wall St target ($4.55)
- CAUTION: Bottoming setup, but lagging the sector by 34% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.91 -
$2.26
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.77
Resistance Level
$2.20
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.55
Wall Street Target
$4.55
(+149.8%)
Revenue Growth (YoY)
-97.6%
Earnings Growth (YoY)
-63.4%
Profit Margin
-147.4%
Share & Embed Analysis
Last updated: October 03, 2026 6:32 AM ET
Data refreshes hourly during market hours. Next update: 7:32 AM
Data refreshes hourly during market hours. Next update: 7:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 62 BUY |